Loading…
Biomerica, Inc. is projected to rise to $2.80 by 2027, a +14% move from its current price of $2.46. BMRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.40 | $2.46 | $2.51 | 0.00% |
| May 30 | $2.38 | $2.46 | $2.54 | 0.00% |
| May 31 | $2.36 | $2.46 | $2.56 | +0.01% |
| Jun 1 | $2.34 | $2.46 | $2.57 | +0.01% |
| Jun 2 | $2.33 | $2.46 | $2.59 | +0.01% |
| Jun 3 | $2.32 | $2.46 | $2.60 | +0.01% |
| Jun 4 | $2.31 | $2.46 | $2.61 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.31 | $2.46 | $2.61 | +0.01% |
| Week 2 | $2.25 | $2.46 | $2.68 | +0.03% |
| Week 3 | $2.21 | $2.46 | $2.73 | +0.04% |
| Week 4 | $2.17 | $2.46 | $2.78 | +0.05% |
| Week 5 | $2.14 | $2.46 | $2.82 | +0.07% |
| Week 6 | $2.11 | $2.46 | $2.86 | +0.08% |
| Week 7 | $2.09 | $2.46 | $2.89 | +0.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Biomerica, Inc. is a biomedical technology company that engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. Its diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations.
It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria.
Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Biomerica, Inc. (BMRA) is categorized in Healthcare and trades as a biomedical technology company focused on diagnostic and therapeutic products. The stock’s current price is $2.49 and it has a market capitalization of $7.69M, with a market rank of 5235.
The current positioning combines a small-cap profile with ongoing product development in GI diseases and related diagnostics.
A major floor 21.8% below — a decisive break under it would weaken the trend.
The nearest floor, 14.1% below — buyers have tended to step in here.
Price is pressing into resistance (1.4% away) — a breakout level to watch.
A major ceiling 11.3% above — clearing it would confirm fresh momentum.
Key BMRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BMRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.44 | Buy | $2.44 | Buy |
| MA 10 | $2.38 | Buy | $2.39 | Buy |
| MA 20 | $2.30 | Buy | $2.33 | Buy |
| MA 50 | $2.20 | Buy | $2.26 | Buy |
| MA 100 | $2.26 | Buy | $2.31 | Buy |
| MA 200 | $2.51 | Sell | $2.57 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.44 | Neutral |
| Stoch RSI (14) | 61.14 | Neutral |
| CCI (20) | 112.48 | Buy |
| Williams %R (14) | -10.34 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 10.81 | Buy |
| Bollinger %B (20,2) | 0.87 | Neutral |
| Stochastic %K (14) | 89.66 | Sell |
| TRIX (15) | 0.38 | Buy |
| Awesome (5,34) | 0.20 | Buy |
| Ultimate (7,14,28) | 64.44 | Neutral |
| Momentum (10) | 0.17 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 2.51 | Sell |
| ADX (14) | 17.77 | Neutral |
| ATR (14) | 0.05 | Info |
Technically, the near-term picture shows bullish sentiment with RSI(14) at 70, and key moving averages at SMA50 $2.18 and SMA200 $2.51. A price near resistance at $2.49 and support at $2.08 frames a tight range for the coming period. The 30-day price range runs from $2.12 to $2.93, indicating noticeable short-term volatility; annualized volatility sits at 50%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.92 | $2.46 | $3.27 | 0% | Neutral | |
| $2.25 | $2.80 | $3.67 | +14% | Neutral | |
| $2.28 | $2.90 | $3.92 | +18% | Neutral | |
| $2.27 | $2.95 | $4.08 | +20% | Neutral | |
| $2.31 | $3.05 | $4.31 | +24% | Bullish | |
| $2.44 | $3.26 | $4.70 | +33% | Bullish | |
| $2.96 | $4.01 | $5.88 | +64% | Bullish | |
| $3.16 | $4.35 | $6.46 | +77% | Bullish | |
| $2.97 | $4.13 | $6.23 | +68% | Bullish | |
| $3.12 | $4.40 | $6.72 | +79% | Bullish | |
| $4.18 | $6.22 | $10.03 | +153% | Bullish | |
| $7.07 | $11.54 | $20.17 | +370% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.92 | $2.46 | $2.88 | +0.00% |
| June 2026 | $2.10 | $2.46 | $2.94 | +0.11% |
| July 2026 | $2.09 | $2.46 | $2.98 | +0.07% |
| August 2026 | $2.15 | $2.55 | $3.11 | +3.65% |
| September 2026 | $2.17 | $2.59 | $3.18 | +1.53% |
| October 2026 | $2.12 | $2.54 | $3.14 | -2.01% |
| November 2026 | $2.12 | $2.54 | $3.17 | +0.33% |
| December 2026 | $2.17 | $2.61 | $3.27 | +2.66% |
Click any year to see its month-by-month BMRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, BMRA could reach as high as $3.27, with a base case around $2.46 and support toward $1.92 — roughly 0% from $2.46. A consolidation phase looks the most probable path here.
Expect BMRA to range from $2.25 to $3.67 through 2027. The $2.80 average target implies a +14% move from current prices. That is up +14% on the projected 2026 average. Price action looks broadly range-bound.
The BMRA price prediction for 2028 points to an average of $2.90 (low $2.28, high $3.92) — a potential gain of +18% on today's $2.46. A consolidation phase looks the most probable path here.
In 2029, BMRA is projected to trade between $2.27 and $4.08, averaging $2.95 — a potential gain of +20% from today's $2.46. That is up +2% on the projected 2028 average. Price action looks broadly range-bound.
Biomerica, Inc.'s 2030 outlook centres on $3.05, within a $2.31 to $4.31 range. That is up +3% on the projected 2029 average. That marks a +24% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, BMRA could reach as high as $4.70, with a base case around $3.26 and support toward $2.44 — roughly +33% from $2.46. Momentum favours further upside here.
Expect BMRA to range from $2.96 to $5.88 through 2032. The $4.01 average target implies a +64% move from current prices. That is up +23% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The BMRA price prediction for 2033 points to an average of $4.35 (low $3.16, high $6.46) — a potential gain of +77% on today's $2.46. Momentum favours further upside here.
In 2034, BMRA is projected to trade between $2.97 and $6.23, averaging $4.13 — a potential gain of +68% from today's $2.46. That is -5% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
Biomerica, Inc.'s 2035 outlook centres on $4.40, within a $3.12 to $6.72 range. That is up +6% on the projected 2034 average. That marks a +79% change versus current levels. Momentum favours further upside here.
By 2040, BMRA could reach as high as $10.03, with a base case around $6.22 and support toward $4.18 — roughly +153% from $2.46. Buyers look set to stay in control over this stretch.
Expect BMRA to range from $7.07 to $20.17 through 2050. The $11.54 average target implies a +370% move from current prices. That is up +85% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BMRA today (≈ 407.331976 BMRA) could be worth
$4,700.3
+$3,700.3 (+370%) by 2050 · US Dollar
Based on the average projected BMRA price of $11.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BMRAwould be worth at today's price.
$1,000 invested in BMRA on May 27, 2025 (≈ 314.465402 BMRA) would be worth
$772.01
-$227.99 (-22.8%) today · 0.77× · US Dollar
Based on a BMRA entry price of $3.18 vs. today's $2.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.35 | $1,044.68 | +4.5% |
| 1 month ago | $2.18 | $1,126.15 | +12.6% |
| 3 months ago | $2.05 | $1,197.56 | +19.8% |
| 6 months ago | $2.37 | $1,035.87 | +3.6% |
| 1 year ago | $3.18 | $772.01 | -22.8% |
| All time (5.0y) ago | $29.2 | $84.08 | -91.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BMRA forecast.
Our base-case forecast reaches $4.90 around 2040.
Implied market cap at $4.90: $15.14M
The multi-year forecast paints a path of gradual appreciation with a sequence of rising averages and notable later-stage strength. For 2026 the avg price is $2.49 with a neutral sentiment and no projected ROI, followed by rising capital appreciation in subsequent years. By 2030 the avg is $3.04 with a 22.2% ROI and bullish sentiment, and by 2040 the avg increases to $6.29 with a 152.7% ROI and bullish sentiment.
In 2050 the avg reaches $11.63 with a 366.9% ROI and bullish sentiment, signaling meaningful upside over the longer horizon. The forecast also shows higher potential max prices (e.g., 2040 max $10.33 and 2050 max $20.75) alongside several intermediate years with substantial upside. These projections, while informative, are estimates and carry inherent uncertainty, especially given the small-cap, high-volatility landscape.
Tap a question to reveal the answer.
2030 min $2.29; avg $3.04; max $4.35; ROI 22.2%; sentiment BULLISH.
2040 max $10.33; avg $6.29; ROI 152.7%; sentiment BULLISH.
2026 min $1.92; avg $2.49; max $3.34; ROI 0%; sentiment NEUTRAL.
Annualized volatility is 50%.
2050 min $6.93; avg $11.63; max $20.75; ROI 366.9%; sentiment BULLISH.
Biomerica, Inc. Community Discussion
0Share your Biomerica, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.